All In Biotech

Drug Trial Radar · NCT05303064

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

A Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth)

Last checked: Nov 19, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 220 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

220

Planned (sponsor's estimate)

Start

Jun 30, 2022

Primary completion

Sep 2026

Study completion Sep 2026

Sponsor

Lead sponsor
Alkermes, Inc.Industry
Sponsor type
Industry
First posted
Mar 31, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 10 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine

Conditions

  • Schizophrenia
  • Bipolar I Disorder

Interventions

  • OLZ/SAMDrug

    OLZ/SAM refers to the fixed dose combination of olanzapine and samidorphan. The starting dose of olanzapine will be 2.5 mg/day or 5 mg/day at the discretion of the Investigator with a maximum daily dose of 20mg/day. The starting dose of samidorphan will be 5 or 10 mg.

  • OlanzapineDrug

    The starting dose of olanzapine will be 2.5 mg/day or 5 mg/day at the discretion of the Investigator with a maximum daily dose of 20mg/day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in body mass index (BMI) Zscore at week 12Time frame: 12 weeks

Locations

47 sites in 5 countries. Site status is shown where the registry gives one.

  • Alkermes Investigator Site

    Dothan, Alabama · Recruiting

  • Alkermes Investigator Site

    Little Rock, Arkansas · Recruiting

  • Alkermes Investigator Site

    Encino, California · Withdrawn

  • Alkermes Investigator Site

    Stanford, California · Recruiting

  • Alkermes Investigator Site

    Upland, California · Withdrawn

  • Alkermes Investigator Site

    Colorado Springs, Colorado · Withdrawn

  • Alkermes Investigator Site

    Denver, Colorado · Active not recruiting

  • Alkermes Investigator Site

    Hartford, Connecticut · Withdrawn

  • Alkermes Investigator Site

    Washington D.C., District of Columbia · Recruiting

  • Alkermes Investigator Site

    Miami, Florida · Withdrawn

  • Alkermes Investigator Site

    Miami Lakes, Florida · Recruiting

  • Alkermes Investigator Site

    Decatur, Georgia · Recruiting

  • Alkermes Investigator Site

    Chicago, Illinois · Recruiting

  • Alkermes Investigator Site

    Indianapolis, Indiana · Recruiting

  • Alkermes Investigator Site

    Saint Charles, Missouri · Recruiting

  • Alkermes Investigator Site

    Lincoln, Nebraska · Recruiting

  • Alkermes Investigator Site

    Omaha, Nebraska · Withdrawn

  • Alkermes Investigator Site

    Paramus, New Jersey · Withdrawn

  • Alkermes Investigator Site

    New York, New York · Recruiting

  • Alkermes Investigational Site

    Kinston, North Carolina · Withdrawn

  • Alkermes Investigator Site

    Cincinnati, Ohio · Recruiting

  • Alkermes Investigator Site

    West Chester, Ohio · Recruiting

  • Alkermes Investigator Site

    DeSoto, Texas · Terminated

  • Alkermes Investigator Site

    Fort Worth, Texas · Withdrawn

  • Alkermes Investigational Site

    Richmond, Virginia · Recruiting

  • Alkermes Investigator Site

    Everett, Washington · Recruiting

  • Alkermes Investigator Site

    Buenos Aires, Argentina · Recruiting

  • Alkermes Investigator Site

    Córdoba, Argentina · Recruiting

  • Alkermes Investigator Site

    Mendoza, Argentina · Recruiting

  • Alkermes Investigator Site

    La Plata, Buenos Aires, Argentina · Recruiting

  • Alkermes Investigator Site

    La Plata, Buenos Aires, Argentina · Recruiting

  • Alkermes Investigator Site

    Goiânia, Brazil · Recruiting

  • Alkermes Investigator Site

    Rio de Janeiro, Brazil · Recruiting

  • Alkermes Investigator Site

    São Paulo, Brazil · Recruiting

  • Alkermes Investigator Site

    São Paulo, Brazil · Recruiting

  • Alkermes Investigator Site

    Fortaleza, Ceará, Brazil · Recruiting

  • Alkermes Investigator Site

    Curitiba, Paraná, Brazil · Recruiting

  • Alkermes Investigator Site

    Barranquilla, Colombia · Recruiting

  • Alkermes Investigator Site

    Bello, Colombia · Recruiting

  • Alkermes Investigator Site

    Bogotá, Colombia · Active not recruiting

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.